Daskalopoulou, Stella S.
Papacostas-Quintanilla, Helena
Brzozowska-Villatte, Romualda
,
Funding for this research was provided by:
Servier
Article History
Received: 11 October 2022
Accepted: 10 December 2024
First Online: 28 December 2024
Declarations
:
: Stella Daskalopoulou was part of the study advisory committee. Helena Papacostas Quintanilla declares no conflict of interest. Romualda Brzozowska-Villate is an employee of Servier, France.
: The study was conducted in compliance with the current revision of the Declaration of Helsinki in accordance with Good Clinical Practice guidelines. The study protocol was approved by an Independent Ethics Committee (Institutional Review Board Services, Ontario IRB registration #IRB00000776—Quebec IRB registration #IRB00005290). All participants provided written informed consent before enrollment.